Department of Internal Medicine

Dr. Njira Lugogo, clinical professor of pulmonary and critical care medicine, was named one of Crain Detroit Business's 2026 Healthcare Heroes.

A new drug called Avapritinib achieved longterm safety approval for indolent systemic mastocytosis.

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.

In this episode of Well-Being at Michigan Medicine with Dr. Elizabeth Harry, Dr. Eve Kerr explores the concept of de-implementation—scaling back unnecessary tests, treatments, and administrative hurdles. Kerr shares how eliminating low-value practices can reduce clinician overload, lower patient costs, and improve overall health outcomes. Discover how both healthcare organizations and local frontline teams can foster a culture of high-value care by eliminating outdated processes.

On this episode of The Fundamentals, we talked to Dr. Thomas J. Wang, dean of the University of Michigan Medical School, about the fundamental questions that have shaped his career and continue to drive biomedical research. Dean Wang discusses his work in cardiovascular research, the enduring impact of the Framingham Heart Study, the potential of AI and emerging health data, and the importance of collaboration between academia and industry. He also shares advice for the next generation of scientists and physicians and explains why sustained investment in biomedical research is essential to improving human health.

Meet Dr. James Henderson, assistant research scientist in the Division of General Medicine. Learn more about his research on using large-scale datasets, like EHR data, to evaluate interventions and improve healthcare delivery.